论文信息 - Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells. - 字舞流文

Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells.

Yana Zhang | Seah H. Lim | Zhiqing Wang | Jian Zhang

[1] Yana Zhang,et al. Semenogelin I expression in myeloma cells can be upregulated pharmacologically. , 2008, Leukemia research.

[2] J. Malm,et al. Characterization of semenogelin proteins in the human retina. , 2004, Experimental eye research.

[3] F. Giles,et al. Pattern of Gene Expression and Immune Responses to Semenogelin 1 in Chronic Hematologic Malignancies , 2003, Journal of immunotherapy.

[4] J. Malm,et al. Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues. , 2002, Molecular human reproduction.

[5] T. Iwamoto,et al. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process. , 2001, Journal of andrology.

[6] H. Lilja,et al. Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20. , 1992, The Journal of biological chemistry.

[7] H. Lilja,et al. Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. , 1989, The Journal of biological chemistry.

[8] A. Green,et al. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. , 1994, Blood.